Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial

Author(s):
Ommen-Nijhof, A. van; Konings, I.R.; Zeijl, C.J.J. van; Uyl-de Groot, C.A.; Noort, V. van der; Jager, A.; Sonke, G.S.; SONIA Study Steering Comm
Published
2018
Publication type
Article / Letter to editor
Advanced breast cancerMetastatic breast cancerPalbociclibRibociclibAbemaciclibCDK46 inhibitorsNon-steroidal aromatase inhibitorsFulvestrant
Date issued
2018-11-20
Language
English
Is part of
BMC Cancer
hdl
1887/86870
doi
10.1186/s12885-018-4978-1